16:21 EDT Zentalis (ZNTL) files $250M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZNTL:
- Zentalis Highlights Promising Azenosertib Data at SGO 2025
- Positive Buy Rating for Zentalis Pharmaceuticals Driven by Promising Efficacy and Safety of Azenosertib in PROC Treatment
- Zentalis presents updated clinical data on azenosertib as SGO 2025
- ZNTL Upcoming Earnings Report: What to Expect?
- Zentalis price target lowered to $6 from $8 at Guggenheim